DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$682M
(+11%)
Cap. Flow
-$874M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
85
Reduced
72
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$72.1M |
| 2 |
Indivior
INDV
|
$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$45.7M |
| 4 |
Merus
MRUS
|
$32.9M |
| 5 |
Viatris
VTRS
|
$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$102M |
| 2 |
Surgery Partners
SGRY
|
$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
$57.6M |
| 4 |
BioNTech
BNTX
|
$49.8M |
| 5 |
Integra LifeSciences
IART
|
$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Quaker Houghton
KWR
$2.51B
| $831K | 0.01% |
4,935
-8,080
| -62% | -$1.36M |
|
177
Varex Imaging
VREX
$484M
| $830K | 0.01% |
69,617
+3,724
| +6% | +$44.4K |
|
178
TFS Financial
TFSL
$3.82B
| $826K | 0.01% |
+64,210
| New | +$826K |
|
179
PPG Industries
PPG
$24.8B
| $823K | 0.01% |
+6,216
| New | +$823K |
|
180
Nike
NKE
$109B
| $823K | 0.01% |
+9,310
| New | +$823K |
|
181
O-I Glass
OI
$1.97B
| $822K | 0.01% |
+62,673
| New | +$822K |
|
|
MODV
182
DELISTED
ModivCare
MODV
| $809K | 0.01% |
56,686
+48,850
| +623% | +$698K |
|
183
Oric Pharmaceuticals
ORIC
$1.06B
| $804K | 0.01% |
+78,435
| New | +$804K |
|
184
Standard Motor Products
SMP
$879M
| $804K | 0.01% |
+24,213
| New | +$804K |
|
185
Zimmer Biomet
ZBH
$20.9B
| $799K | 0.01% |
7,403
+406
| +6% | +$43.8K |
|
186
Progyny
PGNY
$1.94B
| $797K | 0.01% |
47,535
+31,726
| +201% | +$532K |
|
187
Strategic Education
STRA
$1.96B
| $796K | 0.01% |
8,604
+5,055
| +142% | +$468K |
|
188
Uber
UBER
$190B
| $787K | 0.01% |
10,476
-2,233
| -18% | -$168K |
|
|
TWO
189
Two Harbors Investment
TWO
$1.08B
| $785K | 0.01% |
+56,550
| New | +$785K |
|
190
Cencora
COR
$56.7B
| $784K | 0.01% |
+3,485
| New | +$784K |
|
191
Marvell Technology
MRVL
$54.6B
| $782K | 0.01% |
10,840
+7,485
| +223% | +$540K |
|
192
ESCO Technologies
ESE
$5.23B
| $780K | 0.01% |
+6,044
| New | +$780K |
|
193
Aquestive Therapeutics
AQST
$656M
| $773K | 0.01% |
155,145
+8,990
| +6% | +$44.8K |
|
194
Omnicell
OMCL
$1.47B
| $770K | 0.01% |
17,651
-13,823
| -44% | -$603K |
|
195
Salesforce
CRM
$239B
| $768K | 0.01% |
2,806
+1,217
| +77% | +$333K |
|
196
Amalgamated Financial
AMAL
$869M
| $762K | 0.01% |
24,294
-20,203
| -45% | -$634K |
|
|
PMT
197
PennyMac Mortgage Investment
PMT
$1.1B
| $759K | 0.01% |
53,221
+2,716
| +5% | +$38.7K |
|
198
Krystal Biotech
KRYS
$4.35B
| $758K | 0.01% |
4,166
+2,561
| +160% | +$466K |
|
199
Republic Services
RSG
$71.7B
| $757K | 0.01% |
+3,771
| New | +$757K |
|
200
Peoples Bancorp
PEBO
$1.1B
| $752K | 0.01% |
+25,004
| New | +$752K |
|